NO930884D0 - Antimikrobielle karbapenemderivater, samt fremgangsmaate til fremstilling og terapeutisk anvendelse derav - Google Patents

Antimikrobielle karbapenemderivater, samt fremgangsmaate til fremstilling og terapeutisk anvendelse derav

Info

Publication number
NO930884D0
NO930884D0 NO930884A NO930884A NO930884D0 NO 930884 D0 NO930884 D0 NO 930884D0 NO 930884 A NO930884 A NO 930884A NO 930884 A NO930884 A NO 930884A NO 930884 D0 NO930884 D0 NO 930884D0
Authority
NO
Norway
Prior art keywords
carbape
antimicrobial
procedures
derivatives
manufacturing
Prior art date
Application number
NO930884A
Other languages
English (en)
Other versions
NO303730B1 (no
NO930884L (no
Inventor
Isao Kawamoto
Rokuro Endo
Masao Miyauchi
Katsuya Ishikawa
Katsuhiko Watanabe
Hiroshi Yasuda
Satoshi Ohya
Yukio Utsui
Original Assignee
Sankuo Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankuo Company Limited filed Critical Sankuo Company Limited
Publication of NO930884D0 publication Critical patent/NO930884D0/no
Publication of NO930884L publication Critical patent/NO930884L/no
Publication of NO303730B1 publication Critical patent/NO303730B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
NO930884A 1992-03-11 1993-03-11 Antimikrobielle karbapenemderivater NO303730B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5216392 1992-03-11
JP24495392 1992-09-14
JP24657892 1992-09-16

Publications (3)

Publication Number Publication Date
NO930884D0 true NO930884D0 (no) 1993-03-11
NO930884L NO930884L (no) 1993-09-13
NO303730B1 NO303730B1 (no) 1998-08-24

Family

ID=27294566

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930884A NO303730B1 (no) 1992-03-11 1993-03-11 Antimikrobielle karbapenemderivater

Country Status (19)

Country Link
EP (1) EP0560613B1 (no)
KR (1) KR100258225B1 (no)
CN (1) CN1037180C (no)
AT (1) ATE173733T1 (no)
AU (1) AU664422B2 (no)
CA (1) CA2091486A1 (no)
CZ (1) CZ290002B6 (no)
DE (1) DE69322188T2 (no)
DK (1) DK0560613T3 (no)
ES (1) ES2125945T3 (no)
FI (1) FI103046B (no)
HK (1) HK1011976A1 (no)
HU (1) HU218676B (no)
IL (1) IL105020A (no)
MX (1) MX9301361A (no)
NO (1) NO303730B1 (no)
NZ (1) NZ247129A (no)
RU (1) RU2097383C1 (no)
TW (1) TW249803B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2559949B2 (ja) * 1991-06-04 1996-12-04 三共株式会社 １−メチルカルバペネム誘導体
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
ES2181927T3 (es) * 1995-12-21 2003-03-01 Sankyo Co Derivados de 1-metilcarbapenem.
WO1997041123A1 (fr) * 1996-04-26 1997-11-06 Sankyo Company, Limited Derives de 1-methylcarbapeneme
US6946468B1 (en) 1996-08-17 2005-09-20 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
AU1415500A (en) * 1998-12-07 2000-06-26 Sankyo Company Limited 1-methylcarbapenem derivatives
US7041660B2 (en) 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
DK1474426T3 (da) * 2001-09-26 2011-11-21 Merck Sharp & Dohme Fremgangsmåde til fremstilling af carbapenemforbindelser
WO2005063704A1 (ja) * 2003-12-25 2005-07-14 Ono Pharmaceutical Co., Ltd. アゼチジン環化合物およびその医薬
CN101367814B (zh) * 2007-06-28 2010-12-15 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰哌啶取代的培南衍生物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
DE3780344T2 (de) * 1986-03-27 1993-01-28 Sumitomo Pharma Beta-lactam-verbindungen und deren herstellung.
CA2036163C (en) * 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
GB9107363D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
JP2559949B2 (ja) * 1991-06-04 1996-12-04 三共株式会社 １−メチルカルバペネム誘導体
JP3367104B2 (ja) * 1992-04-13 2003-01-14 藤沢薬品工業株式会社 抗菌剤としての置換された３−ピロリジニルチオ−カルバペネム化合物

Also Published As

Publication number Publication date
CZ290002B6 (cs) 2002-05-15
RU2097383C1 (ru) 1997-11-27
CA2091486A1 (en) 1993-09-12
MX9301361A (es) 1994-01-31
IL105020A (en) 1997-04-15
HU9300677D0 (en) 1993-05-28
CN1037180C (zh) 1998-01-28
CN1079472A (zh) 1993-12-15
AU3515193A (en) 1993-09-16
EP0560613A1 (en) 1993-09-15
IL105020A0 (en) 1993-07-08
KR930019674A (ko) 1993-10-18
NO303730B1 (no) 1998-08-24
DK0560613T3 (da) 1999-08-09
CZ39393A3 (en) 1993-12-15
NO930884L (no) 1993-09-13
FI103046B1 (fi) 1999-04-15
FI931079A0 (fi) 1993-03-10
DE69322188D1 (de) 1999-01-07
DE69322188T2 (de) 1999-07-29
TW249803B (no) 1995-06-21
AU664422B2 (en) 1995-11-16
HUT64071A (en) 1993-11-29
NZ247129A (en) 1994-09-27
ES2125945T3 (es) 1999-03-16
FI103046B (fi) 1999-04-15
HU218676B (hu) 2000-10-28
EP0560613B1 (en) 1998-11-25
ATE173733T1 (de) 1998-12-15
FI931079A (fi) 1993-09-12
KR100258225B1 (ko) 2000-08-01
HK1011976A1 (en) 1999-07-23

Similar Documents

Publication Publication Date Title
DE69319976D1 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
DE69331774D1 (de) 7-Substituierte-8-substituierte-9-substituierte Amino-7-Demethyl-6-Deoxy-Tetracycline als antibiotische Mittel
PH30006A (en) 9-¬(Substituted glycol)amido¾-6.demethyl-6-deoxytetra-cyclines
PT618190E (pt) 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas
FI935555A0 (fi) Nya sulfonamider
FI96204C (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
NO930884D0 (no) Antimikrobielle karbapenemderivater, samt fremgangsmaate til fremstilling og terapeutisk anvendelse derav
AU667593B2 (en) Inhibitors of HIV protease useful for the treatment of AIDS
ATE220904T1 (de) 2-phenyl-3-azoylbenzothiophene zur erhöhung der thrombomodulin expression
RU93004678A (ru) Противомикробные производные карбапенема, способы их получения и применение
ES2086651T3 (es) Nuevos compuestos, denominados "leustroducsinas", su preparacion y sus utilizaciones terapeuticas.
ES8703456A1 (es) Procedimiento para preparar derivados de nitrofurano
ATE66221T1 (de) Substituierte 5-amino-pyrazole und diese enthaltende fungizide.
AU6029090A (en) Improvements in or relating to organic compounds
EE9400233A (et) 1,5,6,7-tetrahüdro-4H-indasool-4-ooni sisaldav ravim, uus 1,5,6,7-tetrahüdro-4H-indasool-4-oon ja meetodid nende saamiseks

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003